252 related articles for article (PubMed ID: 38535201)
1. Gut Mycobiome and Asthma.
Kanj AN; Skalski JH
J Fungi (Basel); 2024 Mar; 10(3):. PubMed ID: 38535201
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans.
Kanj AN; Kottom TJ; Schaefbauer KJ; Choudhury M; Limper AH; Skalski JH
Respir Res; 2023 May; 24(1):144. PubMed ID: 37259076
[TBL] [Abstract][Full Text] [Related]
3. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.
Wang LJ; Li SC; Yeh YM; Lee SY; Kuo HC; Yang CY
J Child Psychol Psychiatry; 2023 Sep; 64(9):1280-1291. PubMed ID: 37016804
[TBL] [Abstract][Full Text] [Related]
4. Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions.
Li J; Chen D; Yu B; He J; Zheng P; Mao X; Yu J; Luo J; Tian G; Huang Z; Luo Y
Microb Ecol; 2018 May; 75(4):821-829. PubMed ID: 29110065
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
Yadav A; Yadav R; Sharma V; Dutta U
Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
[TBL] [Abstract][Full Text] [Related]
6. Composition and Associations of the Infant Gut Fungal Microbiota with Environmental Factors and Childhood Allergic Outcomes.
Boutin RCT; Sbihi H; McLaughlin RJ; Hahn AS; Konwar KM; Loo RS; Dai D; Petersen C; Brinkman FSL; Winsor GL; Sears MR; Moraes TJ; Becker AB; Azad MB; Mandhane PJ; Subbarao P; Turvey SE; Finlay BB
mBio; 2021 Jun; 12(3):e0339620. PubMed ID: 34060330
[TBL] [Abstract][Full Text] [Related]
7. Gut mycobiome dysbiosis after sepsis and trauma.
Park G; Munley JA; Kelly LS; Kannan KB; Mankowski RT; Sharma A; Upchurch G; Casadesus G; Chakrabarty P; Wallet SM; Maile R; Bible LE; Wang B; Moldawer LL; Mohr AM; Efron PA; Nagpal R
Crit Care; 2024 Jan; 28(1):18. PubMed ID: 38212826
[TBL] [Abstract][Full Text] [Related]
8. Controlling
Jensen O; Trujillo E; Hanson L; Ost KS
Infect Immun; 2024 Apr; ():e0051623. PubMed ID: 38647290
[TBL] [Abstract][Full Text] [Related]
9. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
10. Mycobiome in the Gut: A Multiperspective Review.
Chin VK; Yong VC; Chong PP; Amin Nordin S; Basir R; Abdullah M
Mediators Inflamm; 2020; 2020():9560684. PubMed ID: 32322167
[TBL] [Abstract][Full Text] [Related]
11. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
[TBL] [Abstract][Full Text] [Related]
12. Host Factors Associated with Gut Mycobiome Structure.
Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
[TBL] [Abstract][Full Text] [Related]
14. Gut mycobiome: A promising target for colorectal cancer.
Qin X; Gu Y; Liu T; Wang C; Zhong W; Wang B; Cao H
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188489. PubMed ID: 33278512
[TBL] [Abstract][Full Text] [Related]
15. Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.
Niu C; Tu Y; Jin Q; Chen Z; Yuan K; Wang M; Zhang P; Luo J; Li H; Yang Y; Liu X; Mao M; Dong T; Tan W; Hu X; Pan Y; Hou L; Ma R; Huang Z
Front Cell Infect Microbiol; 2023; 13():1157368. PubMed ID: 37180439
[TBL] [Abstract][Full Text] [Related]
16. Gut mycobiome dysbiosis contributes to the development of hypertension and its response to immunoglobulin light chains.
Zou Y; Ge A; Lydia B; Huang C; Wang Q; Yu Y
Front Immunol; 2022; 13():1089295. PubMed ID: 36643913
[TBL] [Abstract][Full Text] [Related]
17. Fungal allergic sensitisation in young rural Zimbabwean children: Gut mycobiome and seroreactivity characteristics.
Pfavayi LT; Sibanda EN; Baker S; Woolhouse M; Mduluza T; Mutapi F
Curr Res Microb Sci; 2021 Dec; 2():100082. PubMed ID: 35028627
[TBL] [Abstract][Full Text] [Related]
18. Expansion of Opportunistic Enteric Fungal Pathogens and Occurrence of Gut Inflammation in Human Liver Echinococcosis.
Wang Y; Guo A; Liu Z; Zou Y; Zhu W; Wu S; Zhang S; Guo X; Zhang S; Pu L; Zhu XQ; Zhu G; Cai X; Wang S
Microbiol Spectr; 2022 Oct; 10(5):e0145322. PubMed ID: 36098525
[TBL] [Abstract][Full Text] [Related]
19. "Molding" immunity-modulation of mucosal and systemic immunity by the intestinal mycobiome in health and disease.
Gutierrez MW; van Tilburg Bernardes E; Changirwa D; McDonald B; Arrieta MC
Mucosal Immunol; 2022 Apr; 15(4):573-583. PubMed ID: 35474360
[TBL] [Abstract][Full Text] [Related]
20. Response to Fungal Dysbiosis by Gut-Resident CX3CR1
Li X; Leonardi I; Semon A; Doron I; Gao IH; Putzel GG; Kim Y; Kabata H; Artis D; Fiers WD; Ramer-Tait AE; Iliev ID
Cell Host Microbe; 2018 Dec; 24(6):847-856.e4. PubMed ID: 30503509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
